Call for Abstract
International Conference on Brain Disorders and Dementia Care, will be organized around the theme “Innovative Strategies and Challenges in Brain Health and Dementia Care”
Brain Disorders 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Brain Disorders 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Amongst the induced and later stages of dementia an individual often involves challenging behavioural problems such as anger, sadness, paranoia, confusion and fear that can further result in oppositional, aggressive and sometimes violent actions.
Although there is currently no cure for dementia and no way to stop the underlying death of brain cells, but dementia research has shown that there is still a leeway to improve the essence of life of people living with dementia by providing a supportive environment to them. An individual’s centred care is considered important which characterises a clear perceptive of the individual and giving consideration to their cultural background, personal history, social and family networks and preferences for activities in designing their care.
Diagnosing dementia and Alzheimer is generally difficult, particularly in the initial stages. However diagnosis assessment incorporates medical and patient history to rule out different possible causes. Therefore numerous diagnostic procedures are needed which further includes neurological and physical examination related to blood and urine tests, Mental status assessment to work out the level of mental deterioration, Brain scans (CT Scans and MRI), Caregiver interview to see the level of dependency, Mini Mental State Examination (MMSE) can also be recommended.
Aside from these diagnostics, dementia patient needs reassurance and support from the people closest to them - including their caregivers, friends and family to help the patient to reminisce their sense of existence and feelings of self-worth.
Experts believe that biomarkers offer most promising paths to diagnose Alzheimer’s or dementia. A biomarker is something that can reliably indicate the presence of disease.
Certain possible biomarkers are being studied for their strength to indicate initial stages of Dementia or Alzheimer's disease such as including beta-amyloid and tau levels in cerebrospinal fluid (CSF) and brain changes detectable by imaging. However, three biomarkers have been well-established and validated internationally to diagnose AD in CSF with ELISAs: ?-amyloid (1–42) [A? (1–42)], total tau and phospho-tau-181.
There are a numerous ways to categorise interventions in dementia care, for instance, by the kind of treatment approach used. The chief grouping is by the therapeutic goal, with three considerable spheres recommended: the maintenance of function, including cognitive functions, the management of behaviours that challenge and the reduction of comorbid emotional disorders.
The range of non-pharmacological ‘interventions’ in dementia care is ample and would include the everyday interactions of carers with the person suffering from dementia, the effect of the physical and social conditions and all manner of ‘therapies’, ranging from art sessions to contact with animals.
Brain Disorders 2018 is a unique meeting dedicated to translating the latest developments in the brain mapping and molecular understanding of the causes of Brain Injury and other Brain disorders into new pharmacological therapies in the clinic.
Surviving with dementia from conditions such as Alzheimer’s and related disorders can have an ample of emotional, social, psychological and practical impact on a person. Dementia sufferer finds that their mental abilities are declining, for instance, difficulties to remember things, think clearly, communicate with others, or take care of themselves and often feel vulnerable and need a great deal of reassurance and support.
Dementia is not a disease; it’s actually a comprehensive term that portrays a wide range of symptoms related with a drop in memory or thinking skills severe enough to turn down a person's aptitude to perform everyday activities.
No single test can disclose if someone is demented or not however, Doctors or physicians can almost rules out if a person has dementia using medical evaluations which comprises of medical history, mental status testing (Mini-mental state examination, Mini-Cog test) , physical and neurological exams, blood tests and brain imaging (CT Scans and MRI).Though treatment for dementia is entering an energising stage, following many new medications depending upon the pathogenesis of Alzheimer’s illness.
Dementia is the case that people over 60 fear the most. The most common factors which enhances the risk of developing dementia includes ageing, accumulation of ApoE, Alcohol use, Genetics, Down syndrome, Atherosclerosis, Depression, stroke, Diabetes, Hypertension, Mental illness, smoking, Unhealthy diet, Head injuries and many more.
A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare. They may be assessed by neurological examination, and studied and treated within the specialties of neurology and clinical neuropsychology.
Abstracts and Proposals for Symposia are open under Brain Disorder Session.
- Track 10-1concussions
- Track 10-2Chronic Inflammatory Demyelinating Polyneuropathy
- Track 10-3Trigeminal Neuralgia
- Track 10-4Peripheral Neuropathy
- Track 10-5Narcolepsy
- Track 10-6Challenges of Litigating Brain disorder
- Track 10-7Caregiving & Brain disorder
- Track 10-8Motor Neurone Disease
- Track 10-9Multiple Sclerosis
- Track 10-10Central Nervous System Tumors
- Track 10-11Tuberous Sclerosis
Dementia, also known as senility, is a broad category of brain diseases that cause a long term and often gradual decrease in the ability to think and remember that is great enough to affect a person's daily functioning. Other common symptoms include emotional problems, problems with language, and a decrease in motivation. A person's consciousness is usually not affected. A dementia diagnosis requires a change from a person's usual mental functioning and a greater decline than one would expect due to aging. These diseases also have a significant effect on a person's caregivers.
- Track 11-1Vascular dementia
- Track 11-2Dementia with Lewy bodies
- Track 11-3Mixed dementia
- Track 11-4Frontotemporal dementia
- Track 11-5Creutzfeldt-Jakob disease
Central nervous system diseases, also known as central nervous system disorders, are a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system.There is a wide range of treatments for central nervous system diseases. These can range from surgery to rehabilitation or prescribed medications.
- Track 12-1Bipolar disorder
- Track 12-2Addiction
- Track 12-3Arachnoid cysts
- Track 12-4Epilepsy/Seizures
- Track 12-5Attention deficit/hyperactivity disorder (ADHD)
- Track 12-6Autism
Neurosurgery, or neurological surgery, is the medical specialty concerned with the prevention, diagnosis, surgical treatment, and rehabilitation of disorders which affect any portion of the nervous system including the brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system.
- Track 13-1vascular neurosurgery and endovascular neurosurgery
- Track 13-2stereotactic neurosurgery, functional neurosurgery, and epilepsy surgery
- Track 13-3Oncological neurosurgery ,skull base surgery
- Track 13-4Spinal neurosurgery
- Track 13-5Peripheral nerve surgery
- Track 13-6Paediatric neurosurgery
Pediatric acquired brain injury (PABI) is the number one cause of death and disability for children and young adults in the United States and effects most children ages (6-10) and adolescent ages (11-17) around the world. The injury can be traumatic or non-traumatic in nature, and most patients never return to normal after suffering from the injury. There are many different symptoms such as amnesia, anhedonia, and apraxia. Currently there isn’t a cure for the injury. PABI affects the family of the patient also, because the families of the patient will need to adapt to the new changes they will experience in their child. It is recommended that the families decide to gain as much information as they can about the injury and what to expect by going to different program events and meetings
- Track 14-1Pathophysiology
- Track 14-2Symptoms
- Track 14-3Stem Cells
- Track 14-4Pediatric Brain Tumor Models
A stroke is when poor blood flow to the brain results in cell death. There are two main types of stroke: ischemic, due to lack of blood flow, and haemorrhagic, due to bleeding. They result in part of the brain not functioning properly. Signs and symptoms of a stroke may include an inability to move or feel on one side of the body, problems understanding or speaking, feeling like the world is spinning, or loss of vision to one side.
Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases including amyotrophic lateral sclerosis, Parkinson's, Alzheimer's, and Huntington's occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these similarities offers hope for therapeutic advances that could ameliorate many diseases simultaneously. There are many parallels between different neurodegenerative disorders including atypical protein assemblies as well as induced cell death. Neurodegeneration can be found in many different levels of neuronal circuitry ranging from molecular to systemic.
- Track 16-1Prion disease
Neurotransmitters also known as chemical messengers, are endogenous chemicals that enable neurotransmission. They transmit signals across a chemical synapse, such as a neuromuscular junction, from one neuron (nerve cell) to another "target" neuron, muscle cell, or gland cell. Neurotransmitters are released from synaptic vesicles in synapses into the synaptic cleft, where they are received by receptors on the target cells. Many neurotransmitters are synthesized from simple and plentiful precursors such as amino acids, which are readily available from the diet and only require a small number of biosynthetic steps for conversion. Neurotransmitters play a major role in shaping everyday life and functions. Their exact numbers are unknown, but more than 100 chemical messengers have been uniquely identified muscular atrophy.
Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behaviour. There are two main branches of neuropharmacology: behavioral and molecular. Behavioral neuropharmacology focuses on the study of how drugs affect human behaviour (neuropsychopharmacology), including the study of how drug dependence and addiction affect the human brain. Molecular neuropharmacologyinvolves the study of neurons and their neurochemical interactions, with the overall goal of developing drugs that have beneficial effects on neurological function. Both of these fields are closely connected, since both are concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Studying these interactions, researchers are developing drugs to treat many different neurological disorders, including pain, neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, psychological disorders, addiction, and many others.
Neurology nursing is the field of nursing with a focus on the utmost care of the critically ill or unstable patients following extensive injury, surgery or life threatening diseases. Critical care nurses can be found working in a wide variety of environments and specialties, such as general intensive care units, medical intensive care units, surgical intensive care units, trauma intensive care units, coronary care units, cardio thoracic intensive care units, burns unit, pediatrics and some trauma center emergency departments. These specialists generally take care of critically ill patients who require mechanical ventilation by way of endotracheal incubation and/or titratable vasoactive intravenous medications
- Track 19-1Neurointensive care
- Track 19-2Critical care nursing
- Track 19-3Mental Health Nursing
- Track 19-4Ethical Considerations in Neuro-science Nursing
- Track 19-5Care Practise: Neurology and Nursing
- Track 19-6Neurovascular Nursing
Cognitive neuroscience is the scientific field that is concerned with the study of the biological processes and aspects that underlie cognition with a specific focus on the neural connections in the brain which are involved in mental processes. It addresses the questions of how cognitive activities are affected or controlled by neural circuits in the brain. Cognitive neuroscience is a branch of both neuroscience and psychology, overlapping with disciplines such as physiological psychology, cognitive psychology, and neuropsychology. Cognitive neuroscience relies upon theories in cognitive science coupled with evidence from neuropsychology, and computational modelling.